WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996007102) THERAPEUTIC REMODELING IN AIDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/007102    International Application No.:    PCT/US1995/011004
Publication Date: 07.03.1996 International Filing Date: 29.08.1995
Chapter 2 Demand Filed:    29.03.1996    
IPC:
A61K 38/16 (2006.01), G01N 33/569 (2006.01)
Applicants: WISCONSIN ALUMNI RESEARCH FOUNDATION [US/US]; 614 North Walnut Street, Madison, WI 53705 (US) (For All Designated States Except US).
PAUZA, C., David [US/US]; (US) (For US Only)
Inventors: PAUZA, C., David; (US)
Agent: WOZNY, Thomas, M.; Andrus, Sceales, Starke & Sawall, Suite 1100, 100 East Wisconsin Avenue, Milwaukee, WI 53202 (US).
ELLIS-JONES, Patrick, George, Armine; J A Kemp & Co., 14 South Square, Gray's Inn, London WC1R 5LX (GB)
Priority Data:
08/299,890 01.09.1994 US
Title (EN) THERAPEUTIC REMODELING IN AIDS
(FR) REMODELAGE THERAPEUTIQUE DANS LE TRAITEMENT DU SIDA
Abstract: front page image
(EN)A therapeutic remodeling of immune system for HIV evaluation and AIDS treatment. Specifically, the present invention involves eliciting lymphocytosis in order to reveal the sequestered HIV or SIV in the lymph tissues enabling HIV infection analysis, viral quantification and treatment. The lymphocytosis itself causes an alleviation of the AIDS symptoms and a reduction in the viral load. The present invention could also be used in conjunction with a large variety of adjunct therapies.
(FR)Remodelage thérapeutique du système immunitaire, afin d'évaluer HIV et de traiter le SIDA. Plus particulièrement, l'invention consiste à provoquer la lymphocytose, de manière à révéler HIV ou SIV séquestrés dans les tissus lymphatiques, ce qui permet d'analyser l'infection à HIV, de quantifier le virus et de procéder au traitement. La lymphocytose elle-même provoque un soulagement des symptômes du SIDA et une diminution de la charge virale. On pourrait également utiliser l'invention en combinaison avec une variété importante de thérapies de soutien.
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)